Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic cheilitis: 12-month follow-up results of a prospective, randomized, comparative trial

British Journal of Dermatology

Volumn 173, Issue 1, 2015, Pages 184-191

  Choi, S H ^a   Kim, K H ^a   Song, K H ^a  

^a Dong A University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; AMINOLEVULINIC ACID; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT;

ABLATION THERAPY; ABLATIVE FRACTIONAL LASER ASSISTED PHOTODYNAMIC THERAPY; ACTINIC CHEILITIS; AGED; ANALGESIA; ARTICLE; BURNING SENSATION; CHEILITIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ERBIUM YAG LASER; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; ILLUMINATION; LASER SAFETY; LOW LEVEL LASER THERAPY; MALE; PAIN INTENSITY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; MULTIMODALITY CANCER THERAPY; PHOTOCHEMOTHERAPY; PROCEDURES; RECURRENT DISEASE; SOLID STATE LASER; THERAPEUTIC USE; TREATMENT OUTCOME;

AGED; AMINOLEVULINIC ACID; CHEILITIS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LASER THERAPY; LASERS, SOLID-STATE; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 84947032005     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13542     Document Type: Article

References (32)

1. Markopoulos A, Albanidou-Farmaki E, Kayavis I,. Actinic cheilitis: clinical and pathologic characteristics in 65 cases. Oral Dis 2004; 10: 212-16.
2. Hurwitz RM, Monger LE,. Solar keratosis: an evolving squamous cell carcinoma. Benign or malignant? Dermatol Surg 1995; 21: 184.
3. Frost CA, Green AC,. Epidemiology of solar keratoses. Br J Dermatol 1994; 131: 455-64.
4. Schwartz RA, Bridges TM, Butani AK, Ehrlich A,. Actinic keratosis: an occupational and environmental disorder. J Eur Acad Dermatol Venereol 2008; 22: 606-15.
5. Moy RL,. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: 8-10.
6. Main JH, Pavone M,. Actinic cheilitis and carcinoma of the lip. J Can Dent Assoc 1994; 60: 113-16.
7. Nico MMS, Rivitti E, Lourenco SV,. Actinic cheilitis: histologic study of the entire vermilion and comparison with previous biopsy. J Cutan Pathol 2007; 34: 309-14.
8. Jadotte YT, Schwartz RA,. Solar cheilosis: an ominous precursor part II. Therapeutic perspectives. J Am Acad Dermatol 2012; 66: 187-98.
9. Stender IM, Wulf HC,. Photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic cheilitis. Br J Dermatol 1996; 135: 454-6.
10. Sotiriou E, Apalla Z, Chovarda E, et al,. Photodynamic therapy with 5-aminolevulinic acid in actinic cheilitis: an 18-month clinical and histological follow-up. J Eur Acad Dermatol Venereol 2010; 24: 916-20.
11. Berking C, Herzinger T, Flaig MJ, et al,. The efficacy of photodynamic therapy in actinic cheilitis of the lower lip: a prospective study of 15 patients. Dermatol Surg 2007; 33: 825-30.
12. Sotiriou E, Lallas A, Goussi C, et al,. Sequential use of photodynamic therapy and imiquimod 5% cream for the treatment of actinic cheilitis: a 12-month follow-up study. Br J Dermatol 2011; 165: 888-92.
13. Angell-Petersen E, Sorensen R, Warloe T, et al,. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 2006; 126: 265-71.
14. Kloek J, Beijersbergen van Henegouwen GMJ,. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol 1996; 64: 994-1000.
15. Fritsch C, Homey B, Stahl W, et al,. Preferential relative porphyrin enrichment in solar keratoses upon topical application of 5-aminolevulinic acid methylester. Photochem Photobiol 1998; 68: 218-21.
16. Ko DY, Kim KH, Song KH,. Comparative study of photodynamic therapy using topical methyl aminolevulinate versus 5-aminolevulinic acid for facial actinic keratosis with long-term follow-up: a Korean experience. Ann Dermatol 2014; 26: 321-31.
17. Mikszta JA, Alarcon JB, Brittingham JM, et al,. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 2002; 8: 415-19.
18. Goldberg DJ, Berlin AL, Phelps R,. Histologic and ultrastructural analysis of melasma after fractional resurfacing. Lasers Surg Med 2008; 40: 134-8.
19. Haedersdal M, Sakamoto FH, Farinelli WA, et al,. Fractional CO2 laser-assisted drug delivery. Lasers Surg Med 2010; 42: 113-22.
20. Haedersdal M, Katsnelson J, Sakamoto FH, et al,. Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment. Lasers Surg Med 2011; 43: 804-13.
21. Rossi R, Assad GB, Buggiani G, Lotti T,. Photodynamic therapy: treatment of choice for actinic cheilitis? Dermatol Ther 2008; 21: 412-15.
22. Kodama M, Watanabe D, Akita Y, et al,. Photodynamic therapy for the treatment of actinic cheilitis. Photodermatol Photoimmunol Photomed 2007; 23: 209-10.
23. Alexiades-Armenakas M,. Aminolevulinic acid photodynamic therapy for actinic keratoses/actinic cheilitis/acne: vascular lasers. Dermatol Clin 2007; 25: 25-33.
24. Ko DY, Jeon SY, Kim KH, Song KH,. Fractional erbium: YAG laser-assisted photodynamic therapy for facial actinic keratoses: a randomized, comparative, prospective study. J Eur Acad Dermatol Venereol 2014; 28: 1529-39.
25. Ko DY, Kim KH, Song KH,. A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up. Br J Dermatol 2014; 170: 165-72.
26. Sotiriou E, Apalla Z, Koussidou-Erremonti T, Ioannides D,. Actinic cheilitis treated with one cycle of 5-aminolaevulinic acid-based photodynamic therapy: report of 10 cases. Br J Dermatol 2008; 159: 261-2.
27. Fai D, Romano I, Cassano N, Vena GA,. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic cheilitis: a retrospective evaluation of 29 patients. G Ital Dermatol Venereol 2012; 147: 99-101.
28. Szeimies RM, Karrer S, Radakovic-Fijan S, et al,. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002; 47: 258-62.
29. Togsverd-Bo K, Haak CS, Thaysen-Petersen D, et al,. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Br J Dermatol 2012; 166: 1262-9.
30. Alexiades-Armenakas MR, Dover JS, Arndt KA,. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol 2008; 58: 719-37.
31. Ruiz-Rodriguez R, Lõpez L, Candelas D, Zelickson B,. Enhanced efficacy of photodynamic therapy after fractional resurfacing: fractional photodynamic rejuvenation. J Drugs Dermatol 2007; 6: 818-20.
32. Haak CS, Farinelli WA, Tam J, et al,. Fractional laser-assisted delivery of methyl aminolevulinate: impact of laser channel depth and incubation time. Lasers Surg Med 2012; 44: 787-95.